In human cancers, CEP55-overexpression results in cell transformation, proliferation, epithelial-to-mesenchymal transition, invasion, and cell migration via upregulation of the PI3K/AKT pathway through direct interaction with the p110 catalytic subunit of PI3K14,15. Here, AKT1 is linked to cancer.